CORRECTION article

Front. Pharmacol., 29 August 2024

Sec. Neuropharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1464358

Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

  • KM

    Khlood Mohammad Aldossary 1

  • LS

    Lashin Saad Ali 2,3

  • MS

    Mahmoud S. Abdallah 4,5

  • MM

    Mostafa M. Bahaa 6*

  • TA

    Thanaa A. Elmasry 7

  • EI

    Eman I. Elberri 8

  • FA

    Fedaa A. Kotkata 8

  • RM

    Ramy M. El Sabaa 9

  • YM

    Yasmine M. Elmorsi 8

  • MM

    Mostafa M. Kamel 10

  • WA

    Walaa A. Negm 11

  • AI

    Aya Ibrahim Elberri 12

  • AO

    Amir O. Hamouda 13

  • HA

    Hayam Ali AlRasheed 1

  • MM

    Muhammed M. Salahuddin 13

  • MY

    Mohamed Yasser 14,15

  • MA

    Manal A. Hamouda 9

  • 1. Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia

  • 2. Department of Basic Medical Science, Faculty of Dentistry, Al-Ahliyya Amman University, Amman, Jordan

  • 3. Physiology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt

  • 4. Department of Clinical Pharmacy, Faculty of Pharmacy, University of Sadat City (USC), Sadat City, Menoufia, Egypt

  • 5. Department of PharmD, Faculty of Pharmacy, Jadara University, Irbid, Jordan

  • 6. Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt

  • 7. Pharmacology and Toxicology Department, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt

  • 8. Department of Clinical Pharmacy, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt

  • 9. Department of Clinical Pharmacy, Faculty of Pharmacy, Menoufia University, Shebin El-Kom, Menoufia, Egypt

  • 10. Psychiatry Department, Faculty of Medicine, Tanta University, Egypt

  • 11. Pharmacognosy Department, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt

  • 12. Genetic Engineering and Molecular Biology Division, Department of Zoology, Faculty of Science, Menoufia University, Shebin El-Kom, Menoufia, Egypt

  • 13. Department of Biochemistry and Pharmacology, Faculty of Pharmacy, Horus University, New Damietta, Egypt

  • 14. Department of Pharmaceutics, Faculty of Pharmacy, Port Said University, Port Said, Egypt

  • 15. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Horus University, New Damietta, Egypt

In the published article, there was an error regarding the Affiliation for Manal A. Hamouda. Instead of having the affiliation “7 Pharmacology and Toxicology Department, Faculty of Pharmacy, Tanta University, Tanta, Al-Gharbia, Egypt,” they should be affiliated with “9 Department of Clinical Pharmacy, Faculty of Pharmacy, Menoufia University, Shebin El-Kom, Menoufia, Egypt.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

atorvastatin, major depressive disorder, neuroinflammation, NLRP-3, STAT-3

Citation

Aldossary KM, Saad Ali L, Abdallah MS, Bahaa MM, Elmasry TA, Elberri EI, Kotkata FA, El Sabaa RM, Elmorsi YM, Kamel MM, Negm WA, Elberri AI, Hamouda AO, AlRasheed HA, Salahuddin MM, Yasser M and Hamouda MA (2024) Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study. Front. Pharmacol. 15:1464358. doi: 10.3389/fphar.2024.1464358

Received

13 July 2024

Accepted

20 August 2024

Published

29 August 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Mostafa M. Bahaa,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics